Circulating procoagulant microparticles and soluble GPV in myocardial infarction treated by primary percutaneous transluminal coronary angioplasty. A possible role for GPIIb-IIIa antagonists - Morel, O; Hugel, B; Jesel, L (J Thromb Haemost, 2004)
et al.